Phosphatidylserine-expressing cell by-products in transfusion: A pro-inflammatory or an anti-inflammatory effect?

Saas P, Angelot F, Bardiaux L, Seilles E, Garnache-Ottou F, Perruche S

Open source

DOI
10.1016/j.tracli.2012.02.002
Published
2012 Jun
Container
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.tracli.2012.02.002,
  title = {Phosphatidylserine-expressing cell by-products in transfusion: A pro-inflammatory or an anti-inflammatory effect?},
  author = {Saas P and Angelot F and Bardiaux L and Seilles E and Garnache-Ottou F and Perruche S},
  year = {2012},
  journal = {Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine},
  doi = {10.1016/j.tracli.2012.02.002},
  url = {https://doi.org/10.1016/j.tracli.2012.02.002}
}

RIS

TY  - JOUR
TI  - Phosphatidylserine-expressing cell by-products in transfusion: A pro-inflammatory or an anti-inflammatory effect?
AU  - Saas P
AU  - Angelot F
AU  - Bardiaux L
AU  - Seilles E
AU  - Garnache-Ottou F
AU  - Perruche S
PY  - 2012
JO  - Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine
DO  - 10.1016/j.tracli.2012.02.002
UR  - https://doi.org/10.1016/j.tracli.2012.02.002
ER  - 

APA

P, S., F, A., L, B., E, S., F, G., & S, P. (2012). Phosphatidylserine-expressing cell by-products in transfusion: A pro-inflammatory or an anti-inflammatory effect?. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine. https://doi.org/10.1016/j.tracli.2012.02.002

Source records